FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca CNBC 2025-06-09 20:13 Source Original site Merck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.